Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Molecular imaging of angiogenic therapy in peripheral vascular disease with alphanubeta3-integrin-targeted nanoparticles.

Winter PM, Caruthers SD, Allen JS, Cai K, Williams TA, Lanza GM, Wickline SA.

Magn Reson Med. 2010 Aug;64(2):369-76. doi: 10.1002/mrm.22447.

2.

Anti-angiogenic perfluorocarbon nanoparticles for diagnosis and treatment of atherosclerosis.

Caruthers SD, Cyrus T, Winter PM, Wickline SA, Lanza GM.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2009 May-Jun;1(3):311-23. doi: 10.1002/wnan.9. Review.

PMID:
20049799
4.

A concise review of magnetic resonance molecular imaging of tumor angiogenesis by targeting integrin αvβ3 with magnetic probes.

Liu Y, Yang Y, Zhang C.

Int J Nanomedicine. 2013;8:1083-93. doi: 10.2147/IJN.S39880. Epub 2013 Mar 14. Review.

5.

Targeted contrast agents for magnetic resonance imaging and ultrasound.

Morawski AM, Lanza GA, Wickline SA.

Curr Opin Biotechnol. 2005 Feb;16(1):89-92. Review.

PMID:
15722020
6.

Integrin alpha v beta 3 as a therapeutic target for blocking tumor-induced angiogenesis.

Kumar CC.

Curr Drug Targets. 2003 Feb;4(2):123-31. Review.

PMID:
12558065
7.

Radiolabeled imaging probes targeting angiogenesis for personalized medicine.

Terry SY, Rijpkema M, Abiraj K, van der Graaf WT, Oyen WJ, Boerman OC.

Curr Pharm Des. 2014;20(14):2293-307. Review.

PMID:
24025101
8.

Emerging nanomedicine opportunities with perfluorocarbon nanoparticles.

Winter PM, Cai K, Caruthers SD, Wickline SA, Lanza GM.

Expert Rev Med Devices. 2007 Mar;4(2):137-45. Review.

PMID:
17359221
9.

Integrin targeted drug and gene delivery.

Wang Z, Chui WK, Ho PC.

Expert Opin Drug Deliv. 2010 Feb;7(2):159-71. doi: 10.1517/17425240903468696. Review.

PMID:
20095940
10.

Clinical applications of perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics.

Tran TD, Caruthers SD, Hughes M, Marsh JN, Cyrus T, Winter PM, Neubauer AM, Wickline SA, Lanza GM.

Int J Nanomedicine. 2007;2(4):515-26. Review.

11.

Multimodality tumor imaging targeting integrin alphavbeta3.

Cai W, Sam Gambhir S, Chen X.

Biotechniques. 2005 Dec;39(6 Suppl):S14-25. doi: 10.2144/000112091. Review.

12.

Integrin alpha v beta 3 antagonists for anti-angiogenic cancer treatment.

Hsu AR, Veeravagu A, Cai W, Hou LC, Tse V, Chen X.

Recent Pat Anticancer Drug Discov. 2007 Jun;2(2):143-58. Review.

PMID:
18221059
13.

MRI of tumor angiogenesis.

Barrett T, Brechbiel M, Bernardo M, Choyke PL.

J Magn Reson Imaging. 2007 Aug;26(2):235-49. Review.

PMID:
17623889
14.

Vascular targeting of nanoparticles for molecular imaging of diseased endothelium.

Atukorale PU, Covarrubias G, Bauer L, Karathanasis E.

Adv Drug Deliv Rev. 2016 Sep 15. pii: S0169-409X(16)30261-7. doi: 10.1016/j.addr.2016.09.006. [Epub ahead of print] Review.

PMID:
27639317

Supplemental Content

Support Center